Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel caprolactam antitumor agents under study at Novartis

July 3, 2000

Anti-RHAMM monoclonal antibodies useful for proliferative diseases

July 3, 2000

Small molecule from Novartis is a specific inhibitor of cdk4 kinase

July 3, 2000

Novel alkaloids isolated from Daphniphyllum exert cytotoxic effects against cancer cells

July 3, 2000

Kinase inhibitor PKC-412 exhibits both antiproliferative and antiangiogenic properties

July 3, 2000

Tumor growth and spread blocked by inhibition of RAGE-amphoterin interaction

July 3, 2000

FDA approves Targretin gel for treatment of cutaneous T-cell lymphoma

June 30, 2000

Sch-66336 warrants further evaluation for the treatment of glioblastoma multiforme

June 29, 2000

EB-1089 as a potential agent for the management of refractory thyroid carcinoma

June 29, 2000

PTK-787/ZK-222584 expected to show improved selectivity as kinase inhibitor, according to SAR

June 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...